These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. Kapikian AZ, Hoshino Y, Chanock RM, Pérez-Schael I. J Infect Dis; 1996 Sep; 174 Suppl 1():S65-72. PubMed ID: 8752293 [Abstract] [Full Text] [Related]
10. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. Pérez-Schael I, Guntiñas MJ, Pérez M, Pagone V, Rojas AM, González R, Cunto W, Hoshino Y, Kapikian AZ. N Engl J Med; 1997 Oct 23; 337(17):1181-7. PubMed ID: 9337376 [Abstract] [Full Text] [Related]
11. Jennerian and modified Jennerian approach to vaccination against rotavirus diarrhea using a quadrivalent rhesus rotavirus (RRV) and human-RRV reassortant vaccine. Kapikian AZ, Hoshino Y, Chanock RM, Perez-Schael I. Arch Virol Suppl; 1996 Oct 23; 12():163-75. PubMed ID: 9015113 [Abstract] [Full Text] [Related]
12. Neonatal rotavirus infection: possible effect on prevalence of severe diarrhoea in a community. Bishop RF, Barnes GL. J Paediatr Child Health; 1997 Feb 23; 33(1):80. PubMed ID: 9069052 [No Abstract] [Full Text] [Related]
13. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. Lanata CF, Black RE, del Aguila R, Gil A, Verastegui H, Gerna G, Flores J, Kapikian AZ, Andre FE. J Infect Dis; 1989 Mar 23; 159(3):452-9. PubMed ID: 2536789 [Abstract] [Full Text] [Related]